Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy
- PMID: 11445638
- DOI: 10.1212/wnl.57.1.115
Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy
Abstract
Background: Fukuyama-type congenital muscular dystrophy (FCMD) is an autosomal recessive disorder characterized by severe dystrophic muscle wasting from birth or early infancy with structural brain abnormalities. The gene for FCMD is located on chromosome 9q31, and encodes a novel protein named fukutin. The function of fukutin is not known yet, but is suggested to be an enzyme that modifies the cell-surface glycoprotein or glycolipids.
Objective: To elucidate the roles of fukutin gene mutation in skeletal and cardiac muscles and brain.
Methods: Immunohistochemical and immunoblot analyses were performed in skeletal and cardiac muscles and brain tissue samples from patients with FCMD and control subjects.
Results: The authors found a selective deficiency of highly glycosylated alpha-dystroglycan, but not beta-dystroglycan, on the surface membrane of skeletal and cardiac muscle fibers in patients with FCMD. Immunoblot analyses also showed no immunoreactive band for alpha-dystroglycan, but were positive for beta-dystroglycan in FCMD in skeletal and cardiac muscles.
Conclusion: The current findings suggest a critical role for fukutin gene mutation in the loss or modification of glycosylation of the extracellular peripheral membrane protein, alpha-dystroglycan, which may cause a crucial disruption of the transmembranous molecular linkage of muscle fibers in patients with FCMD.
Similar articles
-
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.Am J Hum Genet. 2001 Dec;69(6):1198-209. doi: 10.1086/324412. Epub 2001 Oct 8. Am J Hum Genet. 2001. PMID: 11592034 Free PMC article.
-
Reduced expression of sarcospan in muscles of Fukuyama congenital muscular dystrophy.Histol Histopathol. 2008 Dec;23(12):1425-38. doi: 10.14670/HH-23.1425. Histol Histopathol. 2008. PMID: 18830929
-
Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.Congenit Anom (Kyoto). 2003 Jun;43(2):97-104. doi: 10.1111/j.1741-4520.2003.tb01033.x. Congenit Anom (Kyoto). 2003. PMID: 12893968 Review.
-
Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.Brain Dev. 2004 Oct;26(7):469-79. doi: 10.1016/j.braindev.2004.01.004. Brain Dev. 2004. PMID: 15351084
-
Functions of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in neuromuscular system and other somatic organs.Cent Nerv Syst Agents Med Chem. 2010 Jun 1;10(2):169-79. doi: 10.2174/187152410791196369. Cent Nerv Syst Agents Med Chem. 2010. PMID: 20518731 Review.
Cited by
-
Milder forms of muscular dystrophy associated with POMGNT2 mutations.Neurol Genet. 2015 Dec 10;1(4):e33. doi: 10.1212/NXG.0000000000000033. eCollection 2015 Dec. Neurol Genet. 2015. PMID: 27066570 Free PMC article.
-
[Cardiac manifestations of muscular dystrophies].Z Kardiol. 2005 May;94(5):312-20. doi: 10.1007/s00392-005-0232-3. Z Kardiol. 2005. PMID: 15868359 Review. German.
-
The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.Cancer Biol Ther. 2015;16(1):125-36. doi: 10.4161/15384047.2014.987078. Cancer Biol Ther. 2015. PMID: 25455932 Free PMC article.
-
Antisense therapy in neurology.J Pers Med. 2013 Aug 2;3(3):144-76. doi: 10.3390/jpm3030144. J Pers Med. 2013. PMID: 25562650 Free PMC article. Review.
-
The congenital muscular dystrophies: recent advances and molecular insights.Pediatr Dev Pathol. 2006 Nov-Dec;9(6):427-43. doi: 10.2350/06-07-0127.1. Pediatr Dev Pathol. 2006. PMID: 17163796 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
